Shree Pacetronix downgraded to 'Sell' by MarketsMOJO due to flat results and bearish trend

Jan 31 2024 04:45 PM IST
share
Share Via
Shree Pacetronix, a microcap company in the medical equipment industry, was downgraded to 'Sell' by MarketsMojo on January 31, 2024 due to flat results in December 2023. The stock is currently in a Mildly Bearish range with a -48.24% return. However, the company has shown high management efficiency and promising long-term growth, making it a potential investment opportunity.
Shree Pacetronix, a microcap company in the medical equipment industry, has recently been downgraded to a 'Sell' by MarketsMOJO on January 31, 2024. This decision was based on the company's flat results in December 2023, with the lowest PBDIT (Profit Before Depreciation, Interest, and Taxes) and PBT (Profit Before Tax) numbers in the last quarter. The operating profit to net sales ratio was also at its lowest at 0.00%, indicating a decline in profitability.

The stock is currently in a Mildly Bearish range, with a deteriorating technical trend since November 2023, resulting in a -48.24% return. Multiple factors, such as MACD, Bollinger Band, and KST, are also indicating a bearish trend for the stock.

However, there are some positive factors to consider. Shree Pacetronix has shown high management efficiency with a ROCE (Return on Capital Employed) of 17.94%. The company also has a low Debt to EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) ratio of 1.28 times, indicating a strong ability to service debt.

In terms of long-term growth, the company has shown promising numbers with an annual growth rate of 65.37% in net sales and 146.17% in operating profit. With a ROCE of 43, the company's valuation is considered Very Attractive, with an Enterprise value to Capital Employed ratio of 5.3. Additionally, the stock is currently trading at a discount compared to its average historical valuations.

Over the past year, Shree Pacetronix has outperformed the market (BSE 500) with a return of 90.14%, while its profits have risen by 291.4%. This has resulted in a low PEG (Price/Earnings to Growth) ratio of 0.1, indicating that the stock is undervalued.

It is worth noting that the majority of the company's shareholders are non-institutional investors. Despite the recent downgrade, Shree Pacetronix has shown market-beating performance, making it a potential investment opportunity for those looking for long-term growth in the medical equipment industry. However, it is important to conduct thorough research and analysis before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News